Hui Li

机构：Guangxi University, Harbin Medical University, Daqing City People's Hospital, Qianjiang Central Hospital, Yangzhou University, Sias University · ORCID：0000-0002-5604-0592

发表论文 683 篇 · 总被引 18527 次 · h-index 66

代表论文

• Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming (2025 · Cell Death and Disease · 被引 23)
• Clematichinenoside AR alleviates rheumatoid arthritis by inhibiting synovial angiogenesis through the HIF-1α/VEGFA/ANG2 axis (2025 · Phytomedicine · 被引 18)
• The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases (2025 · International Journal of Molecular Sciences · 被引 17)
• Engineered crRNA Drives RPA‐T7‐CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047R (2025 · Advanced Science · 被引 15)
• HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism (2025 · Cellular Signalling · 被引 15)
• Quercetagetin alleviates liver fibrosis in non-alcoholic fatty liver disease by promoting ferroptosis of hepatic stellate cells through GPX4 ubiquitination (2025 · Chinese Medicine · 被引 9)